These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33476302)

  • 1. A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes.
    Fisher NM; AlHashim A; Buch AB; Badivuku H; Samman MM; Weiss KM; Cestero GI; Does MD; Rook JM; Lindsley CW; Conn PJ; Gogliotti RG; Niswender CM
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33476302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic
    Song JM; Kang M; Park DH; Park S; Lee S; Suh YH
    J Neurosci; 2021 Mar; 41(11):2344-2359. PubMed ID: 33500274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic profiling of mGlu
    Fisher NM; Gould RW; Gogliotti RG; McDonald AJ; Badivuku H; Chennareddy S; Buch AB; Moore AM; Jenkins MT; Robb WH; Lindsley CW; Jones CK; Conn PJ; Niswender CM
    Genes Brain Behav; 2020 Sep; 19(7):e12654. PubMed ID: 32248644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRM7 gene mutations and consequences for neurodevelopment.
    Freitas GA; Niswender CM
    Pharmacol Biochem Behav; 2023 Apr; 225():173546. PubMed ID: 37003303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.
    Marafi D; Mitani T; Isikay S; Hertecant J; Almannai M; Manickam K; Abou Jamra R; El-Hattab AW; Rajah J; Fatih JM; Du H; Karaca E; Bayram Y; Punetha J; Rosenfeld JA; Jhangiani SN; Boerwinkle E; Akdemir ZC; Erdin S; Hunter JV; Gibbs RA; Pehlivan D; Posey JE; Lupski JR
    Ann Clin Transl Neurol; 2020 May; 7(5):610-627. PubMed ID: 32286009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder.
    Liu Y; Zhang Y; Zhao D; Dong R; Yang X; Tammimies K; Uddin M; Scherer SW; Gai Z
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):258-64. PubMed ID: 25921429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Reduction or Negative Modulation of mGlu
    Fisher NM; Gogliotti RG; Vermudez SAD; Stansley BJ; Conn PJ; Niswender CM
    ACS Chem Neurosci; 2018 Sep; 9(9):2210-2217. PubMed ID: 29227625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse.
    O'Connor RM; Thakker DR; Schmutz M; van der Putten H; Hoyer D; Flor PJ; Cryan JF
    Neuropharmacology; 2013 Sep; 72():66-73. PubMed ID: 23603202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRM7 deficiency, from excitotoxicity and neuroinflammation to neurodegeneration: Systematic review of GRM7 deficient patients.
    Zaki-Dizaji M; Abazari MF; Razzaghi H; Shkolnikov I; Christie BR
    Brain Behav Immun Health; 2024 Aug; 39():100808. PubMed ID: 38983774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior.
    Gee CE; Peterlik D; Neuhäuser C; Bouhelal R; Kaupmann K; Laue G; Uschold-Schmidt N; Feuerbach D; Zimmermann K; Ofner S; Cryan JF; van der Putten H; Fendt M; Vranesic I; Glatthar R; Flor PJ
    J Biol Chem; 2014 Apr; 289(16):10975-10987. PubMed ID: 24596089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRM7-related disorder: five additional patients from three independent families and review of the literature.
    Januel L; Chatron N; Rivier-Ringenbach C; Cabet S; Labalme A; Sahin Y; Darvish H; Kruer M; Bakhtiari S; Sanlaville D; de Sainte Agathe JM; Lesca G
    Eur J Med Genet; 2024 Feb; 67():104893. PubMed ID: 38070825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGlu
    Gogliotti RG; Senter RK; Fisher NM; Adams J; Zamorano R; Walker AG; Blobaum AL; Engers DW; Hopkins CR; Daniels JS; Jones CK; Lindsley CW; Xiang Z; Conn PJ; Niswender CM
    Sci Transl Med; 2017 Aug; 9(403):. PubMed ID: 28814546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phasic and Tonic mGlu7 Receptor Activity Modulates the Thalamocortical Network.
    Tassin V; Girard B; Chotte A; Fontanaud P; Rigault D; Kalinichev M; Perroy J; Acher F; Fagni L; Bertaso F
    Front Neural Circuits; 2016; 10():31. PubMed ID: 27199672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional modulation of glutamatergic synaptic transmission by metabotropic glutamate type 7 receptors at Schaffer collateral-CA1 hippocampal synapses.
    Martín R; Ferrero JJ; Collado-Alsina A; Aguado C; Luján R; Torres M; Sánchez-Prieto J
    J Physiol; 2018 Mar; 596(5):921-940. PubMed ID: 29280494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.
    Fisher NM; Seto M; Lindsley CW; Niswender CM
    Front Mol Neurosci; 2018; 11():387. PubMed ID: 30405350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased amygdalar metabotropic glutamate receptor 7 mRNA in a genetic mouse model of impaired fear extinction.
    O'Connor RM; McCafferty CP; Bravo JA; Singewald N; Holmes A; Cryan JF
    Psychopharmacology (Berl); 2019 Jan; 236(1):265-272. PubMed ID: 30215216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders.
    Parent HH; Niswender CM
    Mol Pharmacol; 2024 Apr; 105(5):348-358. PubMed ID: 38423750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice.
    Dobi A; Sartori SB; Busti D; Van der Putten H; Singewald N; Shigemoto R; Ferraguti F
    Neuropharmacology; 2013 Mar; 66():274-89. PubMed ID: 22643400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology.
    Fendt M; Imobersteg S; Peterlik D; Chaperon F; Mattes C; Wittmann C; Olpe HR; Mosbacher J; Vranesic I; van der Putten H; McAllister KH; Flor PJ; Gee CE
    Neuropharmacology; 2013 Sep; 72():215-23. PubMed ID: 23664812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large consanguineous family with a homozygous Metabotropic Glutamate Receptor 7 (mGlu7) variant and developmental epileptic encephalopathy: Effect on protein structure and ligand affinity.
    Jdila MB; Mignon-Ravix C; Ncir SB; Kammoun F; Fakhfakh F; Villard L; Triki C
    Orphanet J Rare Dis; 2021 Jul; 16(1):317. PubMed ID: 34273994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.